The latest price target for Fabrinet (NYSE:FN) was reported by Rosenblatt on August 20, 2026. The analyst firm set a price target for $750.00 expecting FN to rise to within 12 months (a possible 78.09% upside). 26 analyst firms have reported ratings in the last year.

The latest analyst rating for Fabrinet (NYSE:FN) was provided by Rosenblatt, and Fabrinet maintained their buy rating.

The last upgrade for Fabrinet happened on January 14, 2026 when Barclays raised their price target to $537. Barclays previously had an equal-weight for Fabrinet.

The last downgrade for Fabrinet happened on April 16, 2026 when JP Morgan changed their price target from $530 to $700 for Fabrinet.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fabrinet, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fabrinet was filed on August 20, 2026 so you should expect the next rating to be made available sometime around August 20, 2027.

While ratings are subjective and will change, the latest Fabrinet (FN) rating was a maintained with a price target of $750.00 to $750.00. The current price Fabrinet (FN) is trading at is $421.14, which is out of the analyst’s predicted range.